Cargando…

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence

BACKGROUND: Sleep-related symptoms, especially insomnia, are frequently reported by patients with Parkinson’s disease (PD) and can markedly affect motor symptoms and impair patients’ quality of life. Melatonin has been shown to improve sleep in PD patients. This pilot study aimed at evaluating the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liguori, Claudio, Fernandes, Mariana, Cerroni, Rocco, Ludovisi, Raffaella, Mercuri, Nicola Biagio, Stefani, Alessandro, Pierantozzi, Mariangela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385777/ https://www.ncbi.nlm.nih.gov/pubmed/35536495 http://dx.doi.org/10.1007/s10072-022-06111-x

Ejemplares similares

Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study
por: Carpi, Matteo, et al.
Publicado: (2023)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
por: De Masi, Claudia, et al.
Publicado: (2022)

Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study
por: Gnarra, Oriella, et al.
Publicado: (2023)

Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson’s Disease
por: Cerroni, Rocco, et al.
Publicado: (2022)

Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort
por: Bovenzi, Roberta, et al.
Publicado: (2023)

STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson’s Disease
por: Conti, Matteo, et al.
Publicado: (2022)

Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease
por: Sisto, Renata, et al.
Publicado: (2020)

Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?
por: Stefani, Alessandro, et al.
Publicado: (2022)

Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease
por: Liguori, Claudio, et al.
Publicado: (2015)

Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG
por: Conti, Matteo, et al.
Publicado: (2022)

Adult-onset sporadic chorea: real-world data from a single-centre retrospective study
por: Bovenzi, Roberta, et al.
Publicado: (2021)

Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease
por: Garasto, Elena, et al.
Publicado: (2023)

Psychiatric profile of motor subtypes of de novo drug‐naïve Parkinson's disease patients
por: Assogna, Francesca, et al.
Publicado: (2018)

Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart
por: Olivola, Enrica, et al.
Publicado: (2014)

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Assogna, Francesca, et al.
Publicado: (2021)

Dyspnea perception and neurological symptoms in non-severe COVID-19 patients
por: Ora, Josuel, et al.
Publicado: (2020)

Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson’s Disease and Is Associated with Motor Symptom Severity
por: Ciaramella, Antonio, et al.
Publicado: (2013)

Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism
por: Assogna, Francesca, et al.
Publicado: (2019)

The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer’s Disease: A Special Focus on Cognitive Performance
por: Fernandes, Mariana, et al.
Publicado: (2021)

The Retinal Posterior Pole in Early Parkinson’s Disease: A Fundus Perimetry and SD-OCT Study
por: Cesareo, Massimo, et al.
Publicado: (2021)

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
por: Pisani, Valerio, et al.
Publicado: (2012)

The Sleepiness–Depression Link in Obstructive Sleep Apnea: Preliminary Results on the Mediation of Impulsivity
por: Vacca, Mariacarolina, et al.
Publicado: (2023)

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
por: Schirinzi, Tommaso, et al.
Publicado: (2019)

Can Gut Microbiota Be a Good Predictor for Parkinson’s Disease? A Machine Learning Approach
por: Pietrucci, Daniele, et al.
Publicado: (2020)

Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis
por: Suppa, Antonio, et al.
Publicado: (2023)

Restless Legs Syndrome and Poliomyelitis: New Evidences of an Old Observation?
por: Romigi, Andrea, et al.
Publicado: (2015)

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
por: Liguori, Claudio, et al.
Publicado: (2018)

Bioavailability of Oniria(®), a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers
por: Román Martinez, Manuel, et al.
Publicado: (2022)

Depressive symptoms in Parkinson’s disease and in non-neurological medical illnesses
por: Assogna, Francesca, et al.
Publicado: (2013)

Reduced GABA Content in the Motor Thalamus during Effective Deep Brain Stimulation of the Subthalamic Nucleus
por: Stefani, Alessandro, et al.
Publicado: (2011)

Catecholamine-Based Treatment in AD Patients: Expectations and Delusions
por: Stefani, Alessandro, et al.
Publicado: (2015)

Prolonged–release melatonin in patients with idiopathic REM sleep behavior disorder
por: Jun, Jin‐Sun, et al.
Publicado: (2019)

Prolonged–release melatonin in patients with idiopathic REM sleep behavior disorder
Publicado: (2019)

Changes in the Secretion of Melatonin and Selected Adipokines during the Progression of Parkinson’s Disease—Preliminary Studies
por: Milanowski, Jan, et al.
Publicado: (2023)

Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Chambers, Nicole Elaine, et al.
Publicado: (2020)

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study
por: Garfinkel, Doron, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9gelqviaui9gum6u4romv0gsur